Literature DB >> 32562269

CB1 receptor-dependent desensitisation of TRPV1 channels contributes to the analgesic effect of dipyrone in sensitised primary sensory neurons.

Gilson Goncalves Dos Santos1, Ruihui Li2, Melissa Pui Een Ng2, Julia Borges Paes Lemes1, Willians Fernando Vieira1, Istvan Nagy2, Cláudia Herrera Tambeli1, Carlos Amilcar Parada1.   

Abstract

BACKGROUND AND
PURPOSE: While dipyrone is a widely used analgesic, its mechanism of action is not completely understood. Recently, we have reported that the dipyrone metabolite 4-aminoantipyrine (4-AA) reduces PGE2 -induced pain-related behaviour through cannabinoid CB1 receptors. Here, we ascertained, in naive and PGE2 -induced "inflamed" conditions, both in vivo and in vitro, the molecular mechanisms involved in the 4-AA-induced analgesic effects. EXPERIMENTAL APPROACH: The effect of local administration of 4-AA (160 μg per paw) on capsaicin (0.12 μg per paw) injection-induced pain-related behaviour and 4-AA's effect on 500-nM capsaicin-induced changes in intracellular calcium concentration ([Ca2+ ]i ) in cultured primary sensory neurons were assessed in vivo and in vitro, respectively. KEY
RESULTS: 4-AA reduced capsaicin-induced nociceptive behaviour in naive and inflamed conditions through CB1 receptors. 4-AA (100 μM) reduced capsaicin-induced increase in [Ca2+ ]i in a CB1 receptor-dependent manner, when PGE2 was not present. Following PGE2 application, 4-AA (1-50 μM) increased the [Ca2+ ]i . Although 4-AA activated both TRPV1 and TRPA1 channels, increased [Ca2+ ]i was mediated through TRPV1 channels. Activation of TRPV1 channels resulted in their desensitisation. Blocking CB1 receptors reduced both the excitatory and desensitising effects of 4-AA. CONCLUSION AND IMPLICATIONS: CB1 receptor-mediated inhibition of TRPV1 channels and TRPV1-mediated Ca2+ -influx- and CB1 receptor-dependent desensitisation of TRPV1 channels contribute to the anti-nociceptive effect of 4-AA in naive and inflamed conditions respectively. Agonists active at both CB1 receptors and TRPV1 channels might be useful as analgesics, particularly in inflammatory conditions.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  CB1; TRPA1; TRPV1; calcium imaging; dipyrone; dorsal root ganglion

Mesh:

Substances:

Year:  2020        PMID: 32562269      PMCID: PMC7520441          DOI: 10.1111/bph.15170

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons.

Authors:  Gabor Veress; Zoltan Meszar; Dora Muszil; Antonio Avelino; Klara Matesz; Ken Mackie; Istvan Nagy
Journal:  Brain Struct Funct       Date:  2012-05-22       Impact factor: 3.270

2.  A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control.

Authors:  Eniko Bodó; Tamás Bíró; Andrea Telek; Gabriella Czifra; Zoltán Griger; Balázs I Tóth; Alessandra Mescalchin; Taisuke Ito; Albrecht Bettermann; László Kovács; Ralf Paus
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 3.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Arthur Christopoulos; Anthony P Davenport; Eamonn Kelly; Alistair Mathie; John A Peters; Emma L Veale; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

4.  Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

Authors:  D Melck; T Bisogno; L De Petrocellis; H Chuang; D Julius; M Bifulco; V Di Marzo
Journal:  Biochem Biophys Res Commun       Date:  1999-08-19       Impact factor: 3.575

5.  Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Marco Allarà; Tiziana Bisogno; Stefania Petrosino; Colin G Stott; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

6.  Novel bioactive metabolites of dipyrone (metamizol).

Authors:  Tobias Rogosch; Christian Sinning; Agnes Podlewski; Bernhard Watzer; Joel Schlosburg; Aron H Lichtman; Maria G Cascio; Tiziana Bisogno; Vincenzo Di Marzo; Rolf Nüsing; Peter Imming
Journal:  Bioorg Med Chem       Date:  2011-11-25       Impact factor: 3.641

Review 7.  Systematic review: agranulocytosis induced by nonchemotherapy drugs.

Authors:  Frank Andersohn; Christine Konzen; Edeltraut Garbe
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

8.  Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.

Authors:  O Cohen; E Zylber-Katz; Y Caraco; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1998-09       Impact factor: 2.953

9.  Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons.

Authors:  A Mahmud; P Santha; C C Paule; I Nagy
Journal:  Neuroscience       Date:  2009-05-20       Impact factor: 3.590

10.  Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat.

Authors:  Mohammad Alsalem; Paul Millns; Ahmad Altarifi; Khalid El-Salem; Victoria Chapman; David A Kendall
Journal:  BMC Pharmacol Toxicol       Date:  2016-07-21       Impact factor: 2.483

View more
  2 in total

1.  CB1 receptor-dependent desensitisation of TRPV1 channels contributes to the analgesic effect of dipyrone in sensitised primary sensory neurons.

Authors:  Gilson Goncalves Dos Santos; Ruihui Li; Melissa Pui Een Ng; Julia Borges Paes Lemes; Willians Fernando Vieira; Istvan Nagy; Cláudia Herrera Tambeli; Carlos Amilcar Parada
Journal:  Br J Pharmacol       Date:  2020-09-06       Impact factor: 8.739

2.  Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.

Authors:  Qudong Lu; Yang Yang; Hengshuai Zhang; Cheng Chen; Jiang Zhao; Zhenxing Yang; Yi Fan; Longkun Li; Huan Feng; Jingzhen Zhu; Shanhong Yi
Journal:  Drug Des Devel Ther       Date:  2021-11-15       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.